• Women in the Behavioral Health Industry: Why Executive Leadership Needs a New, Female Face

    When universal education activist and Nobel Prize laureate Malala Yousafzai addressed the United Nations in 2013, she pointed out that “we cannot all succeed when half of us are held back.” Her words resonated with women’s rights advocates as she boldly confronted an inequity that still needs to be addressed today, especially in the behavioral health field.


  • Continuing Care Plan Adherence Following Residential Addiction Treatment

    Common sense suggests that greater patient adherence to substance use disorder (SUD) treatment recommendations is associated with better outcomes. Surprisingly, however, there is limited previous research systematically investigating the adherence-outcome relationship in the context of SUD treatment.


Mark S. Gold

Mark Gold is a translational researcher, author and inventor best known for his work on the brain systems underlying the effects of opiate drugs, cocaine and food. He has published over 1000 peer reviewed scientific articles, texts, and practice guidelines, including citation classics in cocaine neurobiology, opioid addiction neurobiology and treatment, food and process addictions. Dr. Gold has been called a groundbreaking researcher, father of medication assisted recovery, the first to translate rat experiments into theory and treatments for human addicts. He is currently Chairman of Rivermend Health's Scientific Advisory Boards. Dr. Gold was a Professor, Eminent Scholar, Distinguished Professor, Distinguished Alumni Professor, Emeritus Eminent Scholar, and Chairman during his 25 years at the University of Florida. He is currently Adjunct professor at Washington University.